Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank88
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
23.08%
↑ 2544% vs avg
Percentile
P88
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
0.87%
Historical baseline
PeriodValue
Q4 202523.08%
Q3 202521.21%
Q2 202516.46%
Q1 202519.39%
Q4 202413.27%
Q3 2024-36.14%
Q2 2024-18.57%
Q1 2024-14.75%
Q4 2023-7.02%
Q3 2023-83.87%
Q2 202339.22%
Q1 202370.69%
Q4 2022-34.88%
Q3 2022-2.38%
Q2 202214.86%
Q1 2022-5.71%
Q4 20210.00%